SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.1 billion market cap biotech company with a robust current ratio of 3.72, reported selling shares worth $48,029 ...

On February 10, Songjiang sold 2,000 shares at a weighted average price of $11.90 per share, with the actual sale prices ranging between $11.72 and $12.12. The following day, an additional 1,878 ...